Susan M Webb, MD is an expert in Endocrinology at Hospital de Sant Pau (Spain). As of October 2026, ScienceLeadR ranks Susan M Webb in the top 1% of experts worldwide for Hypothalamic Diseases, Pituitary Diseases and Adrenal Gland Diseases. Susan M Webb has authored 410 publications, the most recent in 2026, and is an investigator in 8 clinical trials. SLR score: 1,204 (community average: 125). How the SLR is computed.

LeadR Profile

Susan M Webb, MD Hospital de Sant Pau Spain
1 204 ScienceLeadR Reputation 1204
Network Map

Endocrinology

Subspecialties: Neurology - Public Health - Rheumatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1982 - 2026

Source: PubMed

Hospital de Sant Pau

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 410

Citations

Citations: 12 875 1st author: 68 Last author: 115 Unique author: 14


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Patient-reported measures in hypothalamic-pituitary diseases.
PMID 42823649 — quality of life, pituitary diseases, communication, craniopharyngioma, hormones, health personnel, patient reported outcome measures, therapeutics, nervous system
J Neuroendocrinol20260
MRI-based radiomics prediction of somatostatin receptor ligand response in acromegaly: an automated pipeline study.
PMID 42751035 — somatostatin, neoplasms, classification, acromegaly, receptors, somatostatin, therapeutics, ligands
J Endocr Soc20260
Sex Differences in Endocrine Health: Insights from the EUWIN Community.
PMID 42647751 — diabetes mellitus, thyroid gland, hormones, sex characteristics, sex, endocrine system diseases, sex differences
Eur J Endocrinol20260
Biochemical diagnosis of hypercortisolism: When and how?
PMID 42236015 — endocrinology, vitamins, signs and symptoms, diagnosis, hydrocortisone, cushing syndrome
Vitam Horm20260
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study.
PMID 41879875 — growth, safety, hormones, growth hormone
Pituitary20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6
Phase 3 1
Phase 4 1

By status:

Completed 4
Recruiting 3
Unknown 1

By type:

Observational 5
Interventional 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 2
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map